Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

A Dutch validation study of the Multiple Sclerosis Work Difficulties Questionnaire in relapsing remitting multiple sclerosis.

van Egmond E, van Gorp D, Honan C, Heerings M, Jongen P, van der Klink J, Reneman M, Beenakker E, Frequin S, de Gans K, Hengstman G, Hoitsma E, Mostert J, Verhagen W, Zemel D, Middelkoop H, Visser L, van der Hiele K.

Disabil Rehabil. 2019 Nov 8:1-10. doi: 10.1080/09638288.2019.1686072. [Epub ahead of print]

PMID:
31702954
2.

Mekong delta much lower than previously assumed in sea-level rise impact assessments.

Minderhoud PSJ, Coumou L, Erkens G, Middelkoop H, Stouthamer E.

Nat Commun. 2019 Aug 28;10(1):3847. doi: 10.1038/s41467-019-11602-1.

3.

Cognitive functioning as a predictor of employment status in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.

van Gorp DAM, van der Hiele K, Heerings MAP, Jongen PJ, van der Klink JJL, Reneman MF, Arnoldus EPJ, Beenakker EAC, van Eijk JJJ, Frequin STFM, de Gans K, Hoitsma E, Mostert JP, Verhagen WIM, Zemel D, Visser LH, Middelkoop HAM.

Neurol Sci. 2019 Dec;40(12):2555-2564. doi: 10.1007/s10072-019-03999-w. Epub 2019 Jul 19.

4.

Incidence and Clinical Significance of Cerebral Embolism During Atrial Fibrillation Ablation With Duty-Cycled Phased-Radiofrequency Versus Cooled-Radiofrequency: A Randomized Controlled Trial.

Keçe F, Bruggemans EF, de Riva M, Alizadeh Dehnavi R, Wijnmaalen AP, Meulman TJ, Brugman JA, Rooijmans AM, van Buchem MA, Middelkoop HA, Eikenboom J, Schalij MJ, Zeppenfeld K, Trines SA.

JACC Clin Electrophysiol. 2019 Mar;5(3):318-326. doi: 10.1016/j.jacep.2018.11.008. Epub 2018 Dec 26.

5.

Caregiver strain among life partners of persons with mild disability due to relapsing-remitting multiple sclerosis.

van der Hiele K, van Gorp DAM, Heerings MAP, Jongen PJ, van der Klink JJL, Beenakker EAC, van Eijk JJJ, Frequin STFM, van Geel BM, Hengstman GJD, Hoitsma E, Mostert JP, Verhagen WIM, de Gans K, Zemel D, Middelkoop HAM, Visser LH.

Mult Scler Relat Disord. 2019 Jun;31:5-11. doi: 10.1016/j.msard.2019.03.005. Epub 2019 Mar 6.

6.

Visual Object Perception in Premanifest and Early Manifest Huntington's Disease.

Coppen EM, Jacobs M, van der Zwaan KF, Middelkoop HAM, Roos RAC.

Arch Clin Neuropsychol. 2019 Nov 27;34(8):1320-1328. doi: 10.1093/arclin/acz002.

PMID:
30796801
7.

Systemic features of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a monogenic small vessel disease.

Pelzer N, Hoogeveen ES, Haan J, Bunnik R, Poot CC, van Zwet EW, Inderson A, Fogteloo AJ, Reinders MEJ, Middelkoop HAM, Kruit MC, van den Maagdenberg AMJM, Ferrari MD, Terwindt GM.

J Intern Med. 2019 Mar;285(3):317-332. doi: 10.1111/joim.12848. Epub 2018 Nov 8.

PMID:
30411414
8.

The capability set for work - correlates of sustainable employability in workers with multiple sclerosis.

van Gorp DAM, van der Klink JJL, Abma FI, Jongen PJ, van Lieshout I, Arnoldus EPJ, Beenakker EAC, Bos HM, van Eijk JJJ, Fermont J, Frequin STFM, de Gans K, Hengstman GJD, Hupperts RMM, Mostert JP, Pop PHM, Verhagen WIM, Zemel D, Heerings MAP, Reneman MF, Middelkoop HAM, Visser LH, van der Hiele K.

Health Qual Life Outcomes. 2018 Jun 1;16(1):113. doi: 10.1186/s12955-018-0942-7.

9.

The relation between land use and subsidence in the Vietnamese Mekong delta.

Minderhoud PSJ, Coumou L, Erban LE, Middelkoop H, Stouthamer E, Addink EA.

Sci Total Environ. 2018 Sep 1;634:715-726. doi: 10.1016/j.scitotenv.2018.03.372. Epub 2018 Apr 9.

10.

Coping strategies in relation to negative work events and accommodations in employed multiple sclerosis patients.

van der Hiele K, van Gorp D, Benedict R, Jongen PJ, Arnoldus E, Beenakker E, Bos HM, van Eijk J, Fermont J, Frequin S, van Geel BM, Hengstman G, Hoitsma E, Hupperts R, Mostert JP, Pop P, Verhagen W, Zemel D, Frndak SE, Heerings M, Middelkoop H, Visser LH.

Mult Scler J Exp Transl Clin. 2016 Nov 24;2:2055217316680638. doi: 10.1177/2055217316680638. eCollection 2016 Jan-Dec.

11.

Outcomes of neuropsychiatric events in systemic lupus erythematosus based on clinical phenotypes; prospective data from the Leiden NP SLE cohort.

Magro-Checa C, Beaart-van de Voorde LJ, Middelkoop HA, Dane ML, van der Wee NJ, van Buchem MA, Huizinga TW, Steup-Beekman GM.

Lupus. 2017 Apr;26(5):543-551. doi: 10.1177/0961203316689145.

PMID:
28394225
12.

Value of multidisciplinary reassessment in attribution of neuropsychiatric events to systemic lupus erythematosus: prospective data from the Leiden NPSLE cohort.

Magro-Checa C, Zirkzee EJ, Beaart-van de Voorde LJJ, Middelkoop HA, van der Wee NJ, Huisman MV, Eikenboom J, Kruyt ND, van Buchem MA, Huizinga TWJ, Steup-Beekman GM.

Rheumatology (Oxford). 2017 Oct 1;56(10):1676-1683. doi: 10.1093/rheumatology/kex019.

PMID:
28339952
13.

Cerebral magnetic resonance imaging in quiescent Crohn's disease patients with fatigue.

van Erp S, Ercan E, Breedveld P, Brakenhoff L, Ghariq E, Schmid S, van Osch M, van Buchem M, Emmer B, van der Grond J, Wolterbeek R, Hommes D, Fidder H, van der Wee N, Huizinga T, van der Heijde D, Middelkoop H, Ronen I, van der Meulen-de Jong A.

World J Gastroenterol. 2017 Feb 14;23(6):1018-1029. doi: 10.3748/wjg.v23.i6.1018.

14.

Early Magnetic Resonance Imaging and Cognitive Markers of Hereditary Cerebral Amyloid Angiopathy.

van Rooden S, van Opstal AM, Labadie G, Terwindt GM, Wermer MJ, Webb AG, Middelkoop HA, Greenberg SM, van der Grond J, van Buchem MA.

Stroke. 2016 Dec;47(12):3041-3044. Epub 2016 Nov 10.

15.

Changes in White Matter Microstructure Suggest an Inflammatory Origin of Neuropsychiatric Systemic Lupus Erythematosus.

Magro-Checa C, Ercan E, Wolterbeek R, Emmer B, van der Wee NJ, Middelkoop HA, Kruyt ND, Ronen I, van Buchem MA, Huizinga TW, Steup-Beekman GM.

Arthritis Rheumatol. 2016 Aug;68(8):1945-54. doi: 10.1002/art.39653.

16.

Mild deficits in attentional control in patients with the IGSF1 deficiency syndrome.

Joustra SD, Andela CD, Oostdijk W, van Trotsenburg AS, Fliers E, Wit JM, Pereira AM, Middelkoop HA, Biermasz NR.

Clin Endocrinol (Oxf). 2016 Jun;84(6):896-903. doi: 10.1111/cen.12947. Epub 2015 Oct 15.

PMID:
26387489
17.

Effect of Discontinuation of Antihypertensive Treatment in Elderly People on Cognitive Functioning--the DANTE Study Leiden: A Randomized Clinical Trial.

Moonen JE, Foster-Dingley JC, de Ruijter W, van der Grond J, Bertens AS, van Buchem MA, Gussekloo J, Middelkoop HA, Wermer MJ, Westendorp RG, de Craen AJ, van der Mast RC.

JAMA Intern Med. 2015 Oct;175(10):1622-30. doi: 10.1001/jamainternmed.2015.4103. Erratum in: JAMA Intern Med. 2016 Feb;176(2):284.

PMID:
26301603
18.

The MS@Work study: a 3-year prospective observational study on factors involved with work participation in patients with relapsing-remitting Multiple Sclerosis.

van der Hiele K, van Gorp DA, Heerings MA, van Lieshout I, Jongen PJ, Reneman MF, van der Klink JJ, Vosman F, Middelkoop HA, Visser LH; MS@Work Study Group.

BMC Neurol. 2015 Aug 12;15:134. doi: 10.1186/s12883-015-0375-4.

19.

Association between changes in brain microstructure and cognition in older subjects at increased risk for vascular disease.

Sala M, de Roos A, Blauw GJ, Middelkoop HA, Jukema JW, Mooijaart SP, van Buchem MA, de Craen AJ, van der Grond J.

BMC Neurol. 2015 Aug 7;15:133. doi: 10.1186/s12883-015-0396-z.

20.

Work Participation and Executive Abilities in Patients with Relapsing-Remitting Multiple Sclerosis.

van der Hiele K, van Gorp D, Ruimschotel R, Kamminga N, Visser L, Middelkoop H.

PLoS One. 2015 Jun 17;10(6):e0129228. doi: 10.1371/journal.pone.0129228. eCollection 2015.

21.

Cortical phase changes measured using 7-T MRI in subjects with subjective cognitive impairment, and their association with cognitive function.

van Rooden S, Buijs M, van Vliet ME, Versluis MJ, Webb AG, Oleksik AM, van de Wiel L, Middelkoop HA, Blauw GJ, Weverling-Rynsburger AW, Goos JD, van der Flier WM, Koene T, Scheltens P, Barkhof F, van de Rest O, Slagboom PE, van Buchem MA, van der Grond J.

NMR Biomed. 2016 Sep;29(9):1289-94. doi: 10.1002/nbm.3248. Epub 2014 Dec 19.

PMID:
25522735
22.

A pilot study on factors involved with work participation in the early stages of multiple sclerosis.

Van der Hiele K, Middelkoop HA, Ruimschotel R, Kamminga NG, Visser LH.

PLoS One. 2014 Aug 25;9(8):e105673. doi: 10.1371/journal.pone.0105673. eCollection 2014.

23.

Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE).

Zirkzee EJ, Huizinga TW, Bollen EL, van Buchem MA, Middelkoop HA, van der Wee NJ, le Cessie S, Steup-Beekman GM.

Lupus. 2014;23(1):31-8. doi: 10.1177/0961203313512540. Epub 2013 Nov 15.

PMID:
24243776
24.

Nonlinguistic cognitive impairment in poststroke aphasia: a prospective study.

El Hachioui H, Visch-Brink EG, Lingsma HF, van de Sandt-Koenderman MW, Dippel DW, Koudstaal PJ, Middelkoop HA.

Neurorehabil Neural Repair. 2014 Mar-Apr;28(3):273-81. doi: 10.1177/1545968313508467. Epub 2013 Nov 8.

PMID:
24213963
25.

Longitudinal pilot-study of Sustained Attention to Response Task and P300 in manifest and pre-manifest Huntington's disease.

Hart EP, Dumas EM, van Zwet EW, van der Hiele K, Jurgens CK, Middelkoop HA, van Dijk JG, Roos RA.

J Neuropsychol. 2015 Mar;9(1):10-20. doi: 10.1111/jnp.12031. Epub 2013 Oct 24.

PMID:
24151858
26.

Increased functional connectivity and brain atrophy in elderly with subjective memory complaints.

Hafkemeijer A, Altmann-Schneider I, Oleksik AM, van de Wiel L, Middelkoop HA, van Buchem MA, van der Grond J, Rombouts SA.

Brain Connect. 2013;3(4):353-62. doi: 10.1089/brain.2013.0144. Epub 2013 Jun 21.

27.

A history of futures: A review of scenario use in water policy studies in the Netherlands.

Haasnoot M, Middelkoop H.

Environ Sci Policy. 2012 May;19-20(6):108-120.

28.

A review of cognition in Huntington's disease.

Dumas EM, van den Bogaard SJ, Middelkoop HA, Roos RA.

Front Biosci (Schol Ed). 2013 Jan 1;5:1-18. Review.

PMID:
23277034
29.

Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years.

Hart EP, Dumas EM, Giltay EJ, Middelkoop HA, Roos RA.

J Huntingtons Dis. 2013;2(2):137-47. doi: 10.3233/JHD-130059.

PMID:
25063511
30.

Cerebral atrophy in elderly with subjective memory complaints.

Palm WM, Ferrarini L, van der Flier WM, Westendorp RG, Bollen EL, Middelkoop HA, Milles JR, van der Grond J, van Buchem MA.

J Magn Reson Imaging. 2013 Aug;38(2):358-64. doi: 10.1002/jmri.23977. Epub 2012 Dec 13.

PMID:
23239111
31.

Structural brain changes in migraine.

Palm-Meinders IH, Koppen H, Terwindt GM, Launer LJ, Konishi J, Moonen JM, Bakkers JT, Hofman PA, van Lew B, Middelkoop HA, van Buchem MA, Ferrari MD, Kruit MC.

JAMA. 2012 Nov 14;308(18):1889-97. doi: 10.1001/jama.2012.14276.

32.

Prospective study of clinical phenotypes in neuropsychiatric systemic lupus erythematosus; multidisciplinary approach to diagnosis and therapy.

Zirkzee EJ, Steup-Beekman GM, van der Mast RC, Bollen EL, van der Wee NJ, Baptist E, Slee TM, Huisman MV, Middelkoop HA, Luyendijk J, van Buchem MA, Huizinga TW.

J Rheumatol. 2012 Nov;39(11):2118-26. doi: 10.3899/jrheum.120545. Epub 2012 Sep 15.

PMID:
22984275
33.

Daily hassles reported by Dutch multiple sclerosis patients.

van der Hiele K, Spliethoff-Kamminga NG, Ruimschotel RP, Middelkoop HA, Visser LH.

J Neurol Sci. 2012 Sep 15;320(1-2):85-90. doi: 10.1016/j.jns.2012.06.023. Epub 2012 Jul 15.

PMID:
22795386
34.

Seven-year clinical follow-up of premanifest carriers of Huntington's disease.

Hart E, Middelkoop H, Jurgens CK, Witjes-Ané MN, Roos RA.

PLoS Curr. 2011 Nov 30;3:RRN1288. doi: 10.1371/currents.RRN1288.

35.

Deficient sustained attention to response task and P300 characteristics in early Huntington's disease.

Hart EP, Dumas EM, Reijntjes RH, van der Hiele K, van den Bogaard SJ, Middelkoop HA, Roos RA, van Dijk JG.

J Neurol. 2012 Jun;259(6):1191-8. doi: 10.1007/s00415-011-6334-0. Epub 2011 Dec 6.

36.

Sustained attention to response task (SART) shows impaired vigilance in a spectrum of disorders of excessive daytime sleepiness.

Van Schie MK, Thijs RD, Fronczek R, Middelkoop HA, Lammers GJ, Van Dijk JG.

J Sleep Res. 2012 Aug;21(4):390-5. doi: 10.1111/j.1365-2869.2011.00979.x. Epub 2011 Nov 19.

37.

The relationship between self-reported executive performance and psychological characteristics in multiple sclerosis.

van der Hiele K, Spliethoff-Kamminga NG, Ruimschotel RP, Middelkoop HA, Visser LH.

Eur J Neurol. 2012 Apr;19(4):562-9. doi: 10.1111/j.1468-1331.2011.03538.x. Epub 2011 Oct 18.

PMID:
22008452
38.

Basal ganglia volume is strongly related to P3 event-related potential in premanifest Huntington's disease.

Jurgens CK, van der Hiele K, Reijntjes RH, van de Wiel L, Witjes-Ané MN, van der Grond J, Roos RA, Middelkoop HA, van Dijk JG.

Eur J Neurol. 2011 Aug;18(8):1105-8. doi: 10.1111/j.1468-1331.2010.03309.x. Epub 2011 Jan 25.

PMID:
21749577
39.

Electromyographic activity in the EEG in Alzheimer's disease: noise or signal?

van der Hiele K, Reijntjes RH, Vein AA, Westendorp RG, van Buchem MA, Bollen EL, Middelkoop HA, van Dijk JG.

Int J Alzheimers Dis. 2011 Mar 29;2011:547024. doi: 10.4061/2011/547024.

40.

Shape abnormalities of the striatum in Alzheimer's disease.

de Jong LW, Ferrarini L, van der Grond J, Milles JR, Reiber JH, Westendorp RG, Bollen EL, Middelkoop HA, van Buchem MA.

J Alzheimers Dis. 2011;23(1):49-59. doi: 10.3233/JAD-2010-101026.

PMID:
20930298
41.

MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease.

Jurgens CK, Jasinschi R, Ekin A, Witjes-Ané MN, Middelkoop H, van der Grond J, Roos RA.

PLoS Curr. 2010 Sep 8;2. pii: RRN1173. doi: 10.1371/currents.RRN1173.

42.

Increased psychopathology and maladaptive personality traits, but normal cognitive functioning, in patients after long-term cure of acromegaly.

Tiemensma J, Biermasz NR, van der Mast RC, Wassenaar MJ, Middelkoop HA, Pereira AM, Romijn JA.

J Clin Endocrinol Metab. 2010 Dec;95(12):E392-402. doi: 10.1210/jc.2010-1253. Epub 2010 Sep 15.

PMID:
20843947
43.

Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up.

van Elderen SG, de Roos A, de Craen AJ, Westendorp RG, Blauw GJ, Jukema JW, Bollen EL, Middelkoop HA, van Buchem MA, van der Grond J.

Neurology. 2010 Sep 14;75(11):997-1002. doi: 10.1212/WNL.0b013e3181f25f06.

PMID:
20837967
44.

Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing's disease.

Tiemensma J, Biermasz NR, Middelkoop HA, van der Mast RC, Romijn JA, Pereira AM.

J Clin Endocrinol Metab. 2010 Oct;95(10):E129-41. doi: 10.1210/jc.2010-0512. Epub 2010 Jul 21.

PMID:
20660031
45.

Subtle cognitive impairments in patients with long-term cure of Cushing's disease.

Tiemensma J, Kokshoorn NE, Biermasz NR, Keijser BJ, Wassenaar MJ, Middelkoop HA, Pereira AM, Romijn JA.

J Clin Endocrinol Metab. 2010 Jun;95(6):2699-714. doi: 10.1210/jc.2009-2032. Epub 2010 Apr 6.

PMID:
20371667
46.

Magnetization transfer imaging in 'premanifest' Huntington's disease.

Jurgens CK, Bos R, Luyendijk J, Witjes-Ané MN, van der Grond J, Middelkoop HA, Roos RA.

J Neurol. 2010 Mar;257(3):426-32. doi: 10.1007/s00415-009-5339-4. Epub 2009 Oct 13.

47.

Carotid and basilar artery wall shear stress in Alzheimer's disease and mild cognitive impairment.

van Es AC, van der Flier WM, Box FM, Middelkoop HA, Westendorp RG, van Buchem MA, van der Grond J.

Dement Geriatr Cogn Disord. 2009;28(3):220-4. doi: 10.1159/000237740. Epub 2009 Sep 16.

PMID:
19776573
48.

Basal ganglia volume and clinical correlates in 'preclinical' Huntington's disease.

Jurgens CK, van de Wiel L, van Es AC, Grimbergen YM, Witjes-Ané MN, van der Grond J, Middelkoop HA, Roos RA.

J Neurol. 2008 Nov;255(11):1785-91. doi: 10.1007/s00415-008-0050-4. Epub 2008 Dec 8.

PMID:
19156490
49.

Homozygosity for a NOTCH3 mutation in a 65-year-old CADASIL patient with mild symptoms: a family report.

Liem MK, Lesnik Oberstein SA, Vollebregt MJ, Middelkoop HA, van der Grond J, Helderman-van den Enden AT.

J Neurol. 2008 Dec;255(12):1978-80. doi: 10.1007/s00415-009-0036-x. Epub 2009 Jan 18. No abstract available.

PMID:
19153638
50.

MRI correlates of cognitive decline in CADASIL: a 7-year follow-up study.

Liem MK, Lesnik Oberstein SA, Haan J, van der Neut IL, Ferrari MD, van Buchem MA, Middelkoop HA, van der Grond J.

Neurology. 2009 Jan 13;72(2):143-8. doi: 10.1212/01.wnl.0000339038.65508.96.

PMID:
19139365

Supplemental Content

Loading ...
Support Center